48 results
424B5
OVID
Ovid Therapeutics Inc
15 Nov 23
Prospectus supplement for primary offering
4:11pm
to disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We have elected to adopt the accommodations … available to smaller reporting companies, including but not limited to:
reduced disclosure obligations regarding our executive compensation arrangements
424B5
w7n27aye 69v
20 Nov 20
Prospectus supplement for primary offering
4:23pm